AnaptysBio, Inc.ANABNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-135.69M
↓ 146% below average
Average (9y)
$-55.19M
Historical baseline
Range
High:$-9.08M
Low:$-135.69M
CAGR
+33.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-135.69M | -11.6% |
| 2023 | $-121.61M | -64.4% |
| 2022 | $-73.95M | -56.4% |
| 2021 | $-47.29M | -221.1% |
| 2020 | $-14.73M | +79.1% |
| 2019 | $-70.32M | -41.9% |
| 2018 | $-49.57M | -151.3% |
| 2017 | $-19.73M | -117.3% |
| 2016 | $-9.08M | +8.3% |
| 2015 | $-9.91M | - |